Pediatrix Medical Group Inc (MD)
ROA
Obliczenia
|
2022/Q4 (31 gru 2022) |
2022/Q3 (30 wrz 2022) |
2022/Q2 (30 cze 2022) |
2022/Q1 (31 mar 2022) |
2021/Q4 (31 gru 2021) |
2021/Q3 (30 wrz 2021) |
2021/Q2 (30 cze 2021) |
2021/Q1 (31 mar 2021) |
||
|---|---|---|---|---|---|---|---|---|---|
| Zysk netto (ttm) | w tys. USD | 66 335 | 84 192 | 84 259 | 92 134 | 130 964 | 19 152 | -52 687 | -760 134 |
| Aktywa razem | w tys. USD | 2 347 890 | 2 331 960 | 2 369 620 | 2 340 980 | 2 722 550 | 2 646 100 | 2 555 130 | 2 483 740 |
| ROA | 2,83% | 3,61% | 3,56% | 3,94% | 4,81% | 0,72% | -2,06% | -30,60% |
2022/Q4 obliczenia
ROA = Zysk netto (ttm) ÷ Aktywa razem
= $66 335K ÷ $2 347 890K
= 2,83%
Analiza porównawcza
2022/Q4
Nazwa spółki
Symbol
ROA
Pediatrix Medical Group Inc
MD
2,83%
Acadia Healthcare Company Inc
ACHC
5,48%
Encompass Health Corp
EHC
4,79%
Ensign Group Inc
ENSG
6,51%
HCA Healthcare Inc
HCA
10,76%
Pennant Group Inc
PNTG
1,30%
Select Medical Holdings Corporation
SEM
2,00%
Tenet Healthcare Corp.
THC
1,51%
Universal Health Services, Inc.
UHS
5,00%